New in the treatment of peptic ulcer disease – combination kits (strips).

Abstract

Peptic ulcer disease is a widespread disease of heterogeneous origin. The contamination of the mucous membrane of Helicobacter pylori is the leading cause of the development of this condition. Upon detection of the microorganism, through various studies, a tendency to a more severe course of this disease was revealed, as well as therapy for HP-associated peptic ulcer disease turns out to be less effective. The reason for this was the incomplete eradication of the pathogen, as well as the resistance of the microorganism to certain groups of antibiotics. That is why the selection of effective therapy for the eradication of Helicobacter pylori in HP-associated peptic ulcer disease remains the most important stage for the patient’s recovery. The drug Pilobact AM solves all the questions raised. The ease of use and successful combination of doses of medicines allows for highly effective and safe action on H.pylori and the mucous membrane of the gastrointestinal tract, thereby showing excellent results in the treatment of peptic ulcer disease.